Percentages of hyperdiploidy and nonhyperdiploid karyotypes in training (TR) and test (TE) sets
. | PR . | LB . | MS . | HY . | CD-1 . | CD-2 . | MF . |
|---|---|---|---|---|---|---|---|
| TT2 | |||||||
| Hyperdiploid | 55 | 67 | 43 | 93 | 20 | 20 | 25 |
| Nonhyperdiploid | 45 | 33 | 57 | 7 | 80 | 80 | 75 |
| TT3 | |||||||
| Hyperdiploid | 53 | 25 | 33 | 86 | 0 | 50 | 17 |
| Nonhyperdiploid | 47 | 75 | 67 | 14 | 100 | 50 | 83 |
. | PR . | LB . | MS . | HY . | CD-1 . | CD-2 . | MF . |
|---|---|---|---|---|---|---|---|
| TT2 | |||||||
| Hyperdiploid | 55 | 67 | 43 | 93 | 20 | 20 | 25 |
| Nonhyperdiploid | 45 | 33 | 57 | 7 | 80 | 80 | 75 |
| TT3 | |||||||
| Hyperdiploid | 53 | 25 | 33 | 86 | 0 | 50 | 17 |
| Nonhyperdiploid | 47 | 75 | 67 | 14 | 100 | 50 | 83 |
Values indicate the percentage of the total number of cytogenetics abnormality cases within each subgroup having the variable indicated.
P < .001 for both TT2 and TT3 groups.